SL-164
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 5-chloro-3-(4-chloro-2-methylphenyl)-2-methylquinazolin-4-one | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 3476-88-8 |
| ATC code | None |
| PubChem | CID 63386 |
| Chemical data | |
| Formula | C16H12Cl2N2O |
| Mol. mass | 319.185 |
|
|
SL-164 is an analogue of methaqualone developed in the late 1960s by a team at Sumitomo.[1] SL-164 has similar sedative, hypnotic and anticonvulsant properties to the parent compound, but was never marketed for clinical use.[2]
References [edit]
- ^ US Patent 3651230 COMPOSITIONS AND METHODS FOR TRANQUILIZING WITH SUBSTITUTED 3-PHENYL-4-QUINAZOLINONE DERIVATIVES
- ^ Saito, C.; Sakai, S.; Yukawa, Y.; Yamamoto, H.; Takagi, H. (1969). "Pharmacological studies on 2-methyl-3(2'-methyl-4'-chlorophenyl)-5-chloro-4H)-quinazolinone (SL-164)". Arzneimittel-Forschung 19 (12): 1945–1949. PMID 4985336.
 |
This sedative-related article is a stub. You can help Wikipedia by expanding it. |
